Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claas H Hinze

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|June 25, 2019
ReplyClaas H Hinze, Dirk Foell
Clinical Reviews in Allergy & Immunology|January 4, 2008
B-cell depletion in Wegener's granulomatosisClaas H Hinze, Robert A Colbert
The Journal of Pediatrics|March 27, 2007
B cell depletion: on the riseClaas H Hinze, Alexei A Grom
Nature Reviews. Rheumatology|November 4, 2023
Treatment of systemic juvenile idiopathic arthritisClaas H Hinze, Dirk Foell, Christoph Kessel
Pediatric Rheumatology Online Journal|September 15, 2016
Treatment with high-dose recombinant human hyaluronidase-facilitated subcutaneous immune globulins in patients with juvenile dermatomyositis who are intolerant to intravenous immune globulins: a report of 5 casesFabian Speth, Johannes-Peter Haas, Claas H Hinze
The Pediatric Infectious Disease Journal|September 10, 2009
Kawasaki disease without feverClaas H Hinze, Thomas B Graham, Jamie S Sutherell
Pediatric Rheumatology Online Journal|June 22, 2018
Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologistsClaas H Hinze, Fabian Speth, Prasad T Oommen, et al.
Pediatric Rheumatology Online Journal|March 4, 2018
Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check listFabian Speth, Claas H Hinze, Susanne Andel, et al.
Rheumatology (Oxford, England)|February 12, 2021
A dysregulated interleukin-18-interferon-γ-CXCL9 axis impacts treatment response to canakinumab in systemic juvenile idiopathic arthritisTanja Hinze, Christoph Kessel, Claas H Hinze, et al.
EULAR Rheumatology Open|June 29, 2026
No association of HLA-DRB1*15:01 and HLA-DRB1*11 in systemic juvenile idiopathic arthritis-associated macrophage activation syndrome and other secondary hemophagocytic lymphohistiocytosesClaas H Hinze, Oliver Wegehaupt, Sabrina Fuehner, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Arthritis & Rheumatology (Hoboken, N.J.)|June 25, 2019
ReplyClaas H Hinze, Dirk Foell
Clinical Reviews in Allergy & Immunology|January 4, 2008
B-cell depletion in Wegener's granulomatosisClaas H Hinze, Robert A Colbert
The Journal of Pediatrics|March 27, 2007
B cell depletion: on the riseClaas H Hinze, Alexei A Grom
Nature Reviews. Rheumatology|November 4, 2023
Treatment of systemic juvenile idiopathic arthritisClaas H Hinze, Dirk Foell, Christoph Kessel
Pediatric Rheumatology Online Journal|September 15, 2016
Treatment with high-dose recombinant human hyaluronidase-facilitated subcutaneous immune globulins in patients with juvenile dermatomyositis who are intolerant to intravenous immune globulins: a report of 5 casesFabian Speth, Johannes-Peter Haas, Claas H Hinze
The Pediatric Infectious Disease Journal|September 10, 2009
Kawasaki disease without feverClaas H Hinze, Thomas B Graham, Jamie S Sutherell
Pediatric Rheumatology Online Journal|June 22, 2018
Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologistsClaas H Hinze, Fabian Speth, Prasad T Oommen, et al.
Pediatric Rheumatology Online Journal|March 4, 2018
Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check listFabian Speth, Claas H Hinze, Susanne Andel, et al.
Rheumatology (Oxford, England)|February 12, 2021
A dysregulated interleukin-18-interferon-γ-CXCL9 axis impacts treatment response to canakinumab in systemic juvenile idiopathic arthritisTanja Hinze, Christoph Kessel, Claas H Hinze, et al.
EULAR Rheumatology Open|June 29, 2026
No association of HLA-DRB1*15:01 and HLA-DRB1*11 in systemic juvenile idiopathic arthritis-associated macrophage activation syndrome and other secondary hemophagocytic lymphohistiocytosesClaas H Hinze, Oliver Wegehaupt, Sabrina Fuehner, et al.
Pageof 3